Outcome of patients aged 60‐75 years with newly diagnosed secondary acute myeloid leukemia: A single‐institution experience

A recent phase 3 trial showed that outcome of older patients with secondary acute myeloid leukemia (AML) may be improved by a liposomal encapsulation of cytarabine and daunorubicin (CPX‐351). This phase 3 study represents a unique example of prospective data in this rare subgroup providing basis for...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Bertoli, Sarah, Tavitian, Suzanne, Bories, Pierre, Luquet, Isabelle, Delabesse, Eric, Comont, Thibault, Sarry, Audrey, Huguet, Françoise, Bérard, Emilie, Récher, Christian
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6639188/
https://ncbi.nlm.nih.gov/pubmed/31173485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados